Urokinase Human

Urokinase Human
Cat. No.
BT13499
Source
Human urine.
Synonyms
Urokinase, Abbokinase, Urokinase-type Plasminogen Activator,uPA, EC 3.4.21.73, UK.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity

Greater than 90.0%.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Urokinase is a two-chain glycoprotein containing 411 amino acids with 12 disulfide bonds. Its molecular weight is 54,000 Dalton.

Product Specs

Introduction
Urokinase (UK) is a serine protease that acts as a biological plasminogen activator. It plays a role in various biological processes, including fibrinolysis, embryogenesis, cell migration, tissue remodeling, ovulation, and wound healing. Urokinase can be derived from human urine or kidney cell culture.
Description
Urokinase is a two-chain glycoprotein composed of 411 amino acids and 12 disulfide bonds, with a molecular weight of 54,000 Daltons.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
The Urokinase is lyophilized from a 1 mg/ml solution containing a phosphate buffer.
Solubility
Reconstitute the lyophilized Urokinase in sterile 18 MΩ-cm H2O at a concentration of at least 100 µg/ml. The reconstituted solution can be further diluted in other aqueous solutions.
Stability
Lyophilized Urokinase remains stable at room temperature for 3 weeks but should be stored desiccated below -18°C. After reconstitution, store Urokinase at 4°C for 2-7 days. For long-term storage, store below -18°C. Avoid freeze-thaw cycles.
Purity
Greater than 90.0%
Specific Activity
187,973 IU/mg
Synonyms
Urokinase, Abbokinase, Urokinase-type Plasminogen Activator,uPA, EC 3.4.21.73, UK.
Source
Human urine.
Contaminants
Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.

Product Science Overview

Discovery and Isolation

Urokinase was first discovered by McFarlane and Pilling in 1947, although it was not named at that time . It was originally isolated from human urine, which is reflected in its name. Besides urine, urokinase is also present in the blood and the extracellular matrix of various tissues .

Structure and Function

Urokinase is a 411-residue protein consisting of three domains: the serine protease domain, the kringle domain, and the EGF-like domain . The primary physiological substrate of urokinase is plasminogen, an inactive form of the enzyme plasmin. Urokinase converts plasminogen to plasmin by cleaving a specific peptide bond. Plasmin then participates in a proteolytic cascade that leads to the degradation of fibrin, a key component of blood clots .

Gene and Protein Expression

The gene encoding urokinase in humans is known as PLAU (plasminogen activator, urokinase) . This gene is located on chromosome 10 and is expressed in various tissues. The protein exists in two forms: high molecular weight urokinase (HMW-uPA) and low molecular weight urokinase (LMW-uPA). HMW-uPA can be further processed into LMW-uPA, which is proteolytically active but does not bind to the urokinase receptor .

Medical Applications

Urokinase is used clinically as a thrombolytic agent to dissolve blood clots in patients with conditions such as pulmonary embolism, myocardial infarction, and deep vein thrombosis . It is administered intravenously and works by converting plasminogen to plasmin, which then breaks down fibrin in blood clots .

Biological Functions

Beyond its role in fibrinolysis, urokinase is involved in various biological processes including embryogenesis, cell migration, tissue remodeling, ovulation, and wound healing . It is also detected in many cancers and is thought to play a role in tumor cell migration and proliferation .

Side Effects and Warnings

While urokinase is effective in dissolving blood clots, it carries a risk of severe bleeding, which can be life-threatening . Patients receiving urokinase should be closely monitored for signs of bleeding, and the drug should be used with caution in individuals with conditions that predispose them to bleeding .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.